S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 09:32 PM ET

INCR

InterCure Ltd.

Price Chart

No historical data available

Latest Quote

$0.95

-0.05 (-4.55%)
Current Price
Previous Close $1.00
Open $0.98
Day High $1.00
Day Low $0.95
Volume 12,830
Fetched: 2026-07-16T02:46:46
Stock Information
Note: Financial values converted from ILS to USD
Shares Outstanding 57.15M
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $54.55M
EPS (TTM) $-0.22
Exchange NGM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About InterCure Ltd.

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $76,345,831 $67,595,245 $82,076,665 $75,703,380
Cost Of Revenue $79,350,183 $69,839,972 $83,849,346 $78,205,891
Total Revenue $90,458,653 $79,961,499 $119,033,477 $130,125,208
Operating Revenue $90,458,653 $79,961,499 $119,033,477 $130,125,208
Expenses
Interest Expense $6,582,524 $6,911,617 $8,108,135 $4,917,643
Total Expenses $88,204,552 $95,045,529 $106,447,940 $116,332,104
Rent Expense Supplemental $1,670,238 $1,940,408 $1,994,643 $2,007,700
Other Income Expense $-10,899,899 $-7,424,506 $-26,516,906 $5,608,637
Other Non Operating Income Expenses $-1,408,437 $-3,326,749 $-2,480,080 $-325,075
Net Non Operating Interest Income Expense $-6,119,183 $-6,726,481 $-6,585,872 $-4,724,138
Total Other Finance Cost $57,248 $718,781 $277,201 $89,053
Interest Expense Non Operating $6,582,524 $6,911,617 $8,108,135 $4,917,643
Operating Expense $8,854,369 $25,205,557 $22,598,594 $38,126,213
Other Operating Expenses $-23,356,880 $-11,013,391 $-10,070,305 -
Selling And Marketing Expense $6,782,725 $7,268,162 $7,344,158 $6,798,795
General And Administrative Expense $20,138,266 $21,064,948 $21,526,615 $25,781,720
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-11,955,139 $-22,696,685 $-20,742,886 $15,004,687
Net Interest Income $-6,119,183 $-6,726,481 $-6,585,872 $-4,724,138
Interest Income $520,589 $903,917 $1,799,464 $282,558
Normalized Income $-3,956,156 $-19,280,770 $-2,234,530 $9,083,561
Net Income From Continuing And Discontinued Operation $-11,955,139 $-22,696,685 $-20,742,886 $15,004,687
Total Operating Income As Reported $-9,120,857 $-22,500,167 $-13,915,969 $16,949,113
Net Income Common Stockholders $-11,955,139 $-22,696,685 $-20,742,886 $15,004,687
Net Income $-11,955,139 $-22,696,685 $-20,742,886 $15,004,687
Net Income Including Noncontrolling Interests $-12,314,697 $-24,369,936 $-21,269,836 $14,646,468
Net Income Continuous Operations $-12,314,697 $-24,369,936 $-21,269,836 $14,646,468
Pretax Income $-14,764,981 $-29,234,348 $-20,517,241 $14,677,603
Special Income Charges $0 $0 $-23,018,748 $3,539,337
Earnings From Equity Interest $99,096 $0 $0 -
Interest Income Non Operating $520,589 $903,917 $1,799,464 $282,558
Operating Income $2,254,101 $-15,084,031 $12,585,537 $13,793,103
Depreciation Amortization Depletion Income Statement $2,736,525 $2,901,239 $2,635,085 $1,414,128
Depreciation And Amortization In Income Statement $2,736,525 $2,901,239 $2,635,085 $1,414,128
Depreciation Income Statement $2,736,525 $2,901,239 $2,635,085 $1,414,128
Gross Profit $11,108,470 $10,121,526 $35,184,131 $51,919,316
Per Share
Diluted EPS - - $-0.46 $0.33
Basic EPS - - $-0.46 $0.33
Other
Tax Effect Of Unusual Items $-1,591,577 $-681,841 $-5,528,470 $12,587
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $7,148,979 $-13,079,009 $16,035,487 $17,578,172
Total Unusual Items $-9,590,559 $-4,097,757 $-24,036,826 $5,933,713
Total Unusual Items Excluding Goodwill $-9,590,559 $-4,097,757 $-24,036,826 $5,933,713
Reconciled Depreciation $5,740,877 $5,145,966 $4,407,767 $3,916,639
EBITDA (Bullshit earnings) $-2,441,580 $-17,176,766 $-8,001,339 $23,511,885
EBIT $-8,182,457 $-22,322,732 $-12,409,106 $19,595,246
Diluted NI Availto Com Stockholders $-11,955,139 $-22,696,685 $-20,742,886 $15,004,687
Minority Interests $359,558 $1,673,251 $526,950 $358,219
Tax Provision $-2,450,285 $-4,864,412 $752,595 $31,135
Impairment Of Capital Assets $0 $0 $22,661,533 $0
Restructuring And Mergern Acquisition $0 $0 $357,215 $-3,539,337
Gain On Sale Of Security $-9,590,559 $-4,097,757 $-1,018,078 $2,394,376
Provision For Doubtful Accounts $2,423,167 $4,845,999 $1,033,144 $3,919,987
Research And Development $130,566 $138,601 $129,896 $211,584
Selling General And Administration $26,920,991 $28,333,110 $28,870,773 $32,580,515
Other Gand A $4,737,864 $4,133,579 $3,986,943 $4,001,674
Insurance And Claims $414,797 $549,046 $585,537 $718,781
Rent And Landing Fees $1,670,238 $1,940,408 $1,994,643 $2,007,700
Salaries And Wages $13,315,366 $14,441,915 $14,959,491 $19,053,565
Diluted Average Shares - $15,356,269 $15,257,010 $15,183,328
Basic Average Shares - $15,356,269 $15,257,010 $15,183,328
Fetched: 2026-07-16
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $59,358,975 $57,700,676 $78,339,694 $72,679,923
Total Assets $231,154,852 $255,263,441 $263,310,573 $320,682,535
Total Non Current Assets $125,127,536 $124,112,272 $123,120,440 $137,415,144
Non Current Deferred Assets $15,394,323 $12,842,271 $8,261,699 $6,907,344
Non Current Deferred Taxes Assets $15,394,323 $12,842,271 $8,261,699 $6,907,344
Non Current Accounts Receivable $1,603,401 $141,595 $1,408,248 -
Investmentin Financial Assets $40,838 $718,685 $643,369 $858,606
Financial Assets Designatedas Fair Value Through Profitor Loss Total $40,838 $718,685 $643,369 $858,606
Goodwill And Other Intangible Assets $73,372,163 $75,180,425 $74,004,151 $95,126,532
Current Assets $106,027,315 $131,151,169 $140,190,133 $176,572,606
Restricted Cash $680,860 $440,517 $3,233,581 $4,655,219
Prepaid Assets $1,842,070 $2,011,113 $10,292,897 $1,454,107
Inventory $36,173,261 $41,952,199 $35,579,769 $49,038,629
Receivables $51,707,170 $60,419,763 $57,166,098 $43,499,364
Other Receivables $42,410,123 $29,182,902 $22,233,046 $4,215,037
Loans Receivable $2,065,006 $13,676,441 $13,567,651 $21,541,140
Accounts Receivable $7,088,773 $17,354,891 $20,221,932 $12,358,238
Allowance For Doubtful Accounts Receivable $-2,335,810 $-2,594,229 $-1,735,623 $-551,316
Gross Accounts Receivable $9,424,583 $19,949,120 $21,957,555 $12,909,554
Cash Cash Equivalents And Short Term Investments $15,623,954 $26,327,576 $33,917,788 $77,925,287
Cash And Cash Equivalents $15,553,994 $26,216,108 $33,855,192 $77,856,665
Cash Equivalents $414,407 $20,267,457 $2,115,552 $13,469,238
Cash Financial $15,139,586 $5,948,651 $31,739,640 $64,387,428
Non Current Note Receivables - $0 $6,174,935 -
Debt
Net Debt $37,757,247 $35,179,755 $23,183,036 -
Total Debt $61,261,633 $70,765,214 $65,500,770 $85,412,064
Long Term Debt And Capital Lease Obligation $26,427,328 $45,919,529 $34,425,588 $41,101,292
Long Term Debt $19,903,595 $38,153,244 $27,516,235 $33,368,146
Current Debt And Capital Lease Obligation $34,834,304 $24,845,685 $31,075,183 $44,310,772
Current Debt $33,407,646 $23,242,619 $29,521,993 $42,854,991
Other Current Borrowings $33,407,646 $23,242,619 $29,521,993 $42,854,991
Liabilities
Total Liabilities Net Minority Interest $98,478,611 $122,147,353 $110,313,986 $146,123,720
Total Non Current Liabilities Net Minority Interest $26,722,234 $46,245,230 $34,707,103 $41,444,400
Current Liabilities $71,756,377 $75,902,123 $75,606,883 $104,679,320
Other Current Liabilities $992,837 $12,708,710 $1,366,406 $3,424,382
Payables And Accrued Expenses $35,929,236 $38,347,727 $41,799,558 $52,858,339
Payables $30,149,294 $33,545,223 $37,615,653 $49,313,785
Other Payable $7,338,823 $7,589,543 $11,358,707 $7,114,213
Accounts Payable $22,810,471 $25,955,681 $26,256,946 $42,199,572
Current Deferred Liabilities - $0 $1,365,736 $4,085,827
Equity
Common Stock Equity $132,731,138 $132,881,101 $152,343,845 $167,806,455
Total Equity Gross Minority Interest $132,676,241 $133,116,088 $152,996,587 $174,558,815
Stockholders Equity $132,731,138 $132,881,101 $152,343,845 $167,806,455
Other Equity Interest $6,557,876 - - $2,859,008
Gains Losses Not Affecting Retained Earnings $5,338,756 $5,338,756 $5,338,756 $799,357
Other Equity Adjustments $5,338,756 $5,338,756 $5,338,756 $799,357
Retained Earnings $-105,313,986 $-92,916,583 $-68,285,131 $-47,415,479
Long Term Equity Investment $301,600 $0 - $13,389,570
Other
Ordinary Shares Number $18,303,989 $15,787,211 $15,254,967 $15,254,968
Share Issued $18,303,989 $15,319,482 $15,254,967 $15,254,968
Tangible Book Value $59,358,975 $57,700,676 $78,339,694 $72,679,923
Invested Capital $186,042,379 $194,276,964 $209,382,073 $244,029,592
Working Capital $34,270,938 $55,249,046 $64,583,250 $71,893,286
Capital Lease Obligations $7,950,392 $9,369,351 $8,462,543 $9,188,927
Total Capitalization $152,634,733 $171,034,345 $179,860,080 $201,174,601
Minority Interest $-54,897 $234,987 $652,742 $6,752,360
Capital Stock $226,148,492 $220,458,929 $215,290,220 $211,563,568
Common Stock $226,148,492 $220,458,929 $215,290,220 $211,563,568
Employee Benefits $294,905 $325,701 $281,516 $343,108
Long Term Capital Lease Obligation $6,523,733 $7,766,285 $6,909,353 $7,733,146
Current Capital Lease Obligation $1,426,659 $1,603,066 $1,553,190 $1,455,781
Current Accrued Expenses $5,779,942 $4,802,504 $4,183,906 $3,544,554
Investments And Advances $342,438 $718,685 $643,369 $858,606
Investmentsin Associatesat Cost $301,600 $0 - $13,389,570
Goodwill $73,372,163 $75,180,425 $74,004,151 $95,126,532
Net PPE $34,415,211 $35,229,297 $32,628,038 $34,522,662
Accumulated Depreciation $-23,942,224 $-18,230,568 $-13,446,475 $-7,761,599
Gross PPE $58,357,435 $53,459,865 $46,074,513 $42,284,261
Other Properties $14,818,906 $14,590,614 $12,062,329 $11,304,144
Machinery Furniture Equipment $9,371,360 $8,311,241 $7,835,911 $7,504,184
Buildings And Improvements $34,167,169 $30,558,010 $26,176,274 $23,475,932
Properties $0 $0 $0 $0
Other Inventories $19,080 $1,681,395 $275,156 $2,130,615
Finished Goods $6,067,149 $20,990,159 $20,241,012 $16,783,825
Work In Process $30,087,032 $19,280,645 $15,063,601 $30,124,188
Duefrom Related Parties Current $143,268 $205,530 $1,143,469 $5,384,950
Other Short Term Investments $69,961 $111,468 $62,596 $68,622
Current Deferred Revenue - - $0 $2,697,998
Fetched: 2026-07-16
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $4,449,354 $-23,867,577 $-18,829,082 $10,552,655
Operating Activities
Operating Cash Flow $5,637,344 $-22,402,758 $-17,952,400 $17,161,077
Cash Flow From Continuing Operating Activities $5,637,344 $-22,402,758 $-17,952,400 $17,161,077
Operating Gains Losses $1,062,462 $-335,409 $76,321 $139,921
Investing Activities
Capital Expenditure $-1,187,990 $-1,464,819 $-876,682 $-6,608,422
Investing Cash Flow $-666,466 $5,921,202 $1,597,710 $-47,699,337
Cash Flow From Continuing Investing Activities $-666,466 $5,921,202 $1,597,710 $-47,699,337
Net Other Investing Changes $-350,137 $7,250,452 $3,589,074 $-36,242,552
Financing Activities
Issuance Of Capital Stock $502,109 $11,381,134 $0 $0
Financing Cash Flow $-15,618,263 $8,855,527 $-27,746,201 $40,318,003
Cash Flow From Continuing Financing Activities $-15,618,263 $8,855,527 $-27,746,201 $40,318,003
Cash Dividends Paid $0 $0 $0 $0
Net Common Stock Issuance $502,109 $11,381,134 $0 $0
Common Stock Issuance $502,109 $11,381,134 $0 $0
Net Other Financing Charges - $-32,804 - -
Other
Repayment Of Debt $-16,830,354 $-60,486,711 $-41,744,661 $-42,091,451
Issuance Of Debt $7,079,735 $63,078,597 $20,996,854 $88,195,087
End Cash Position $15,553,994 $26,216,108 $33,855,192 $77,856,665
Beginning Cash Position $26,216,108 $33,855,192 $77,856,665 $65,681,529
Effect Of Exchange Rate Changes $-14,729 $-13,055 $99,418 $2,395,394
Changes In Cash $-10,647,386 $-7,626,029 $-44,100,891 $9,779,742
Interest Paid Cff $-6,369,753 $-5,084,689 $-6,998,393 $-5,785,633
Net Issuance Payments Of Debt $-9,750,619 $2,591,886 $-20,747,808 $46,103,636
Net Long Term Debt Issuance $-9,750,619 $2,591,886 $-20,747,808 $46,103,636
Long Term Debt Payments $-16,830,354 $-60,486,711 $-41,744,661 $-42,091,451
Long Term Debt Issuance $7,079,735 $63,078,597 $20,996,854 $88,195,087
Interest Received Cfi $314,320 $0 $282,855 $0
Net Business Purchase And Sale $557,341 $135,569 $-1,405,905 $-4,848,363
Sale Of Business $813,416 $370,891 $0 $522,193
Purchase Of Business $-256,076 $-235,322 $-1,405,905 $-5,370,556
Net PPE Purchase And Sale $-1,187,990 $-1,464,819 $-868,314 $-6,608,422
Sale Of PPE $0 $0 $8,368 $0
Purchase Of PPE $-1,187,990 $-1,464,819 $-876,682 $-6,608,422
Taxes Refund Paid $102,430 $-4,313,785 $-2,547,700 $-2,668,206
Change In Working Capital $6,319,542 $-3,076,923 $-30,519,181 $-1,010,243
Change In Payables And Accrued Expense $-2,128,942 $-1,679,722 $-14,383,745 $18,819,375
Change In Payable $-2,128,942 $-1,679,722 $-14,383,745 $18,819,375
Change In Account Payable $-2,951,061 $-2,979,179 $-15,942,626 $19,091,183
Change In Inventory $5,338,087 $-5,837,183 $13,458,861 $-25,436,165
Change In Receivables $3,110,397 $4,439,981 $-29,594,296 $5,606,548
Changes In Account Receivables $10,324,362 $2,820,848 $-7,863,694 $-6,121,042
Other Non Cash Items $5,643,369 $8,769,164 $7,398,072 $-931,245
Stock Based Compensation $813,082 $763,540 $867,644 $2,981,522
Unrealized Gain Loss On Investment Securities $719,355 $-124,188 $221,263 $57,575
Asset Impairment Charge $0 $0 $22,658,499 $0
Deferred Tax $-2,449,956 $-4,863,761 $752,494 $31,131
Deferred Income Tax $-2,449,956 $-4,863,761 $752,494 $31,131
Depreciation Amortization Depletion $5,740,108 $5,145,277 $4,407,177 $3,916,114
Depreciation And Amortization $5,740,108 $5,145,277 $4,407,177 $3,916,114
Depreciation $5,740,108 $5,145,277 $4,407,177 $3,916,114
Pension And Employee Benefit Expense $-30,796 $44,186 $-61,592 $139,921
Gain Loss On Sale Of PPE $0 $131,887 $137,913 $0
Gain Loss On Sale Of Business $1,093,258 $-511,482 $0 $0
Net Income From Continuing Operations $-12,313,048 $-24,366,673 $-21,266,988 $14,644,507
Proceeds From Stock Option Exercised - - $0 $0
Net Investment Purchase And Sale - - - $0
Purchase Of Investment - - - $0
Interest Received Cfo - - - -
Interest Paid Cfo - - - -
Change In Other Current Assets - - - -
Earnings Losses From Equity Investments - - - -
Fetched: 2026-07-16